Analysts Set Intuitive Surgical, Inc. (NASDAQ:ISRG) Price Target at $396.17

Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) have been given a consensus rating of “Moderate Buy” by the seventeen research firms that are currently covering the firm, Marketbeat reports. Four investment analysts have rated the stock with a hold rating and thirteen have assigned a buy rating to the company. The average 1 year target price among analysts that have updated their coverage on the stock in the last year is $396.17.

A number of research firms have issued reports on ISRG. Raymond James increased their target price on shares of Intuitive Surgical from $372.00 to $435.00 and gave the stock an “outperform” rating in a research report on Thursday, January 25th. Stifel Nicolaus increased their price target on shares of Intuitive Surgical from $420.00 to $430.00 and gave the company a “buy” rating in a report on Monday, April 8th. StockNews.com downgraded shares of Intuitive Surgical from a “buy” rating to a “hold” rating in a report on Thursday, February 29th. Piper Sandler lifted their price target on shares of Intuitive Surgical from $425.00 to $435.00 and gave the company an “overweight” rating in a report on Friday, April 19th. Finally, Jefferies Financial Group lifted their price target on shares of Intuitive Surgical from $365.00 to $375.00 and gave the company a “hold” rating in a report on Friday, April 19th.

Intuitive Surgical Stock Performance

Shares of NASDAQ:ISRG opened at $374.14 on Friday. The company has a market cap of $132.71 billion, a PE ratio of 67.53, a price-to-earnings-growth ratio of 4.85 and a beta of 1.36. Intuitive Surgical has a 52 week low of $254.85 and a 52 week high of $403.76. The firm has a 50 day simple moving average of $386.10 and a 200 day simple moving average of $347.50.

Intuitive Surgical (NASDAQ:ISRG) last issued its quarterly earnings results on Thursday, April 18th. The medical equipment provider reported $1.50 EPS for the quarter, beating the consensus estimate of $1.40 by $0.10. The business had revenue of $1.89 billion during the quarter, compared to the consensus estimate of $1.87 billion. Intuitive Surgical had a net margin of 27.16% and a return on equity of 12.91%. The firm’s quarterly revenue was up 11.5% on a year-over-year basis. During the same quarter in the prior year, the firm earned $1.00 EPS. On average, equities analysts predict that Intuitive Surgical will post 4.8 earnings per share for the current year.

Insider Transactions at Intuitive Surgical

In related news, Director Alan J. Levy sold 2,000 shares of the business’s stock in a transaction that occurred on Tuesday, April 23rd. The shares were sold at an average price of $370.70, for a total transaction of $741,400.00. Following the completion of the transaction, the director now owns 25,319 shares in the company, valued at $9,385,753.30. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. In related news, President David J. Rosa sold 80,710 shares of the business’s stock in a transaction that occurred on Wednesday, February 7th. The shares were sold at an average price of $389.28, for a total transaction of $31,418,788.80. Following the completion of the transaction, the president now owns 163,399 shares in the company, valued at $63,607,962.72. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, Director Alan J. Levy sold 2,000 shares of the business’s stock in a transaction that occurred on Tuesday, April 23rd. The shares were sold at an average price of $370.70, for a total transaction of $741,400.00. Following the transaction, the director now owns 25,319 shares of the company’s stock, valued at approximately $9,385,753.30. The disclosure for this sale can be found here. Insiders sold a total of 225,093 shares of company stock worth $87,153,299 in the last quarter. 0.80% of the stock is owned by company insiders.

Institutional Inflows and Outflows

Institutional investors have recently bought and sold shares of the stock. Portside Wealth Group LLC lifted its position in shares of Intuitive Surgical by 8.2% in the fourth quarter. Portside Wealth Group LLC now owns 816 shares of the medical equipment provider’s stock worth $275,000 after purchasing an additional 62 shares in the last quarter. Sequoia Financial Advisors LLC lifted its position in Intuitive Surgical by 58.0% during the fourth quarter. Sequoia Financial Advisors LLC now owns 8,315 shares of the medical equipment provider’s stock worth $2,805,000 after purchasing an additional 3,054 shares during the period. Kades & Cheifetz LLC bought a new stake in Intuitive Surgical during the fourth quarter worth about $230,000. Blair William & Co. IL lifted its position in Intuitive Surgical by 3.1% during the third quarter. Blair William & Co. IL now owns 377,371 shares of the medical equipment provider’s stock worth $110,302,000 after purchasing an additional 11,400 shares during the period. Finally, Assenagon Asset Management S.A. lifted its holdings in shares of Intuitive Surgical by 21.2% in the third quarter. Assenagon Asset Management S.A. now owns 739,471 shares of the medical equipment provider’s stock worth $216,140,000 after acquiring an additional 129,194 shares during the last quarter. Institutional investors own 83.64% of the company’s stock.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.